Literature DB >> 26862167

Antigen clasping by two antigen-binding sites of an exceptionally specific antibody for histone methylation.

Takamitsu Hattori1, Darson Lai1, Irina S Dementieva1, Sherwin P Montaño1, Kohei Kurosawa1, Yupeng Zheng2, Louesa R Akin1, Kalina M Świst-Rosowska3, Adrian T Grzybowski4, Akiko Koide1, Krzysztof Krajewski5, Brian D Strahl5, Neil L Kelleher2, Alexander J Ruthenburg6, Shohei Koide7.   

Abstract

Antibodies have a well-established modular architecture wherein the antigen-binding site residing in the antigen-binding fragment (Fab or Fv) is an autonomous and complete unit for antigen recognition. Here, we describe antibodies departing from this paradigm. We developed recombinant antibodies to trimethylated lysine residues on histone H3, important epigenetic marks and challenging targets for molecular recognition. Quantitative characterization demonstrated their exquisite specificity and high affinity, and they performed well in common epigenetics applications. Surprisingly, crystal structures and biophysical analyses revealed that two antigen-binding sites of these antibodies form a head-to-head dimer and cooperatively recognize the antigen in the dimer interface. This "antigen clasping" produced an expansive interface where trimethylated Lys bound to an unusually extensive aromatic cage in one Fab and the histone N terminus to a pocket in the other, thereby rationalizing the high specificity. A long-neck antibody format with a long linker between the antigen-binding module and the Fc region facilitated antigen clasping and achieved both high specificity and high potency. Antigen clasping substantially expands the paradigm of antibody-antigen recognition and suggests a strategy for developing extremely specific antibodies.

Entities:  

Keywords:  antibody engineering; antibody validation; data reproducibility; epigenetics; protein–protein interaction

Mesh:

Substances:

Year:  2016        PMID: 26862167      PMCID: PMC4776465          DOI: 10.1073/pnas.1522691113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The language of covalent histone modifications.

Authors:  B D Strahl; C D Allis
Journal:  Nature       Date:  2000-01-06       Impact factor: 49.962

2.  Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

Authors:  E O Saphire; P W Parren; R Pantophlet; M B Zwick; G M Morris; P M Rudd; R A Dwek; R L Stanfield; D R Burton; I A Wilson
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

3.  Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen.

Authors:  Abigail V J Collis; Adam P Brouwer; Andrew C R Martin
Journal:  J Mol Biol       Date:  2003-01-10       Impact factor: 5.469

4.  High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

Authors:  D Neri; M Momo; T Prospero; G Winter
Journal:  J Mol Biol       Date:  1995-02-24       Impact factor: 5.469

5.  Calibrating ChIP-Seq with Nucleosomal Internal Standards to Measure Histone Modification Density Genome Wide.

Authors:  Adrian T Grzybowski; Zhonglei Chen; Alexander J Ruthenburg
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

6.  Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2.

Authors:  Lianying Jiao; Xin Liu
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

7.  Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition.

Authors:  E Vargas-Madrazo; F Lara-Ochoa; J C Almagro
Journal:  J Mol Biol       Date:  1995-12-01       Impact factor: 5.469

8.  Directed network wiring identifies a key protein interaction in embryonic stem cell differentiation.

Authors:  Norihisa Yasui; Greg M Findlay; Gerald D Gish; Marilyn S Hsiung; Jin Huang; Monika Tucholska; Lorne Taylor; Louis Smith; W Clifford Boldridge; Akiko Koide; Tony Pawson; Shohei Koide
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

9.  An assessment of histone-modification antibody quality.

Authors:  Thea A Egelhofer; Aki Minoda; Sarit Klugman; Kyungjoon Lee; Paulina Kolasinska-Zwierz; Artyom A Alekseyenko; Ming-Sin Cheung; Daniel S Day; Sarah Gadel; Andrey A Gorchakov; Tingting Gu; Peter V Kharchenko; Samantha Kuan; Isabel Latorre; Daniela Linder-Basso; Ying Luu; Queminh Ngo; Marc Perry; Andreas Rechtsteiner; Nicole C Riddle; Yuri B Schwartz; Gregory A Shanower; Anne Vielle; Julie Ahringer; Sarah C R Elgin; Mitzi I Kuroda; Vincenzo Pirrotta; Bing Ren; Susan Strome; Peter J Park; Gary H Karpen; R David Hawkins; Jason D Lieb
Journal:  Nat Struct Mol Biol       Date:  2010-12-05       Impact factor: 15.369

10.  Recombinant antibodies to histone post-translational modifications.

Authors:  Takamitsu Hattori; Joseph M Taft; Kalina M Swist; Hao Luo; Heather Witt; Matthew Slattery; Akiko Koide; Alexander J Ruthenburg; Krzysztof Krajewski; Brian D Strahl; Kevin P White; Peggy J Farnham; Yingming Zhao; Shohei Koide
Journal:  Nat Methods       Date:  2013-08-18       Impact factor: 28.547

View more
  14 in total

Review 1.  Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis.

Authors:  Malik R Seals; Monica M Moran; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

2.  Engineering Binders with Exceptional Selectivity.

Authors:  Kai Wen Teng; Akiko Koide; Shohei Koide
Journal:  Methods Mol Biol       Date:  2022

3.  Windows of opportunity for Ebola virus infection treatment and vaccination.

Authors:  Van Kinh Nguyen; Esteban A Hernandez-Vargas
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Synthetic oligonucleotide antigens modified with locked nucleic acids detect disease specific antibodies.

Authors:  Simone V Samuelsen; Ilia A Solov'yov; Imelda M Balboni; Elizabeth Mellins; Christoffer Tandrup Nielsen; Niels H H Heegaard; Kira Astakhova
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

5.  Chromatin-enriched lncRNAs can act as cell-type specific activators of proximal gene transcription.

Authors:  Michael S Werner; Matthew A Sullivan; Rohan N Shah; Rangarajan D Nadadur; Adrian T Grzybowski; Vasiliy Galat; Ivan P Moskowitz; Alexander J Ruthenburg
Journal:  Nat Struct Mol Biol       Date:  2017-06-19       Impact factor: 15.369

6.  IgM Antibodies Can Access Cryptic Antigens Denied to IgG: Hypothesis on Novel Binding Mechanism.

Authors:  Eric Chun Yiu Law; Danny Tze Ming Leung; Frankie Chi Hang Tam; Kitty Kit Ting Cheung; Naomi Hua Yin Cheng; Pak Leong Lim
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

7.  Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope.

Authors:  Katharina Imkeller; Stephen W Scally; Alexandre Bosch; Gemma Pidelaserra Martí; Giulia Costa; Gianna Triller; Rajagopal Murugan; Valerio Renna; Hassan Jumaa; Peter G Kremsner; B Kim Lee Sim; Stephen L Hoffman; Benjamin Mordmüller; Elena A Levashina; Jean-Philippe Julien; Hedda Wardemann
Journal:  Science       Date:  2018-06-07       Impact factor: 47.728

Review 8.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

9.  Systematic comparison of monoclonal versus polyclonal antibodies for mapping histone modifications by ChIP-seq.

Authors:  Michele Busby; Catherine Xue; Catherine Li; Yossi Farjoun; Elizabeth Gienger; Ido Yofe; Adrianne Gladden; Charles B Epstein; Evan M Cornett; Scott B Rothbart; Chad Nusbaum; Alon Goren
Journal:  Epigenetics Chromatin       Date:  2016-11-04       Impact factor: 4.954

Review 10.  Biology and Physics of Heterochromatin-Like Domains/Complexes.

Authors:  Prim B Singh; Stepan N Belyakin; Petr P Laktionov
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.